Routine, coordinated treatment of opioid abuse can stem national epidemic

July 14, 2018 by Franny White, Oregon Health & Science University

To help stem the nationwide opioid epidemic and related increases in HIV, hepatitis C and other infections, health care providers should routinely screen and treat patients for opioid abuse when they come to clinics and hospitals seeking other services.

That's one of five recommendations outlined in a paper published in the Annals of Internal Medicine. The paper supports a newly published document that outlines the proceedings of a March 12, 2018, workshop convened on the topic by the National Academies of Sciences, Engineering and Medicine.

"Treatment can save lives," said one of the paper's authors, Todd Korthuis, M.D., M.P.H. "The national opioid epidemic can turn around if we embrace opioid use disorder as a that needs treatment instead of a moral issue or the result of poor willpower."

Korthuis, who is a professor of medicine (general internal medicine and geriatrics) and head of addiction in the OHSU School of Medicine, also participated in the National Academies workshop and reviewed the resulting proceedings document. He co-wrote the paper with Sandra A. Springer, M.D., of the Yale School of Medicine and Carlos del Rio, M.D., of the Emory University School of Medicine, both of whom also participated in the workshop.

The highlighted one of the many dire consequences of the opioid epidemic: more people are turning to injection drug use after their prescriptions are cut off, which in turn has led to an increase in life-threatening infections of the skin, joint, blood, bone and more. These serious infections require expensive and lengthy hospital treatments, but most hospital staff don't regularly address the root cause: drug addiction.

Explore further: National Academies target opioid abuse and infectious disease consequences

More information: Sandra A. Springer et al, Integrating Treatment at the Intersection of Opioid Use Disorder and Infectious Disease Epidemics in Medical Settings: A Call for Action After a National Academies of Sciences, Engineering, and Medicine Workshop, Annals of Internal Medicine (2018). DOI: 10.7326/M18-1203

Related Stories

National Academies target opioid abuse and infectious disease consequences

July 13, 2018
The National Academies of Sciences, Engineering, and Medicine (NASEM) today released proceedings of a March 12 workshop exploring the rise in infectious diseases accompanying opioid abuse, and possible strategies for reducing ...

Stigma continues to hamper response to opioid epidemic

January 10, 2018
Efforts to reverse the nation's opioid epidemic remain beset by the stigma associated with drug use, a group of OHSU researchers write in a year-end review.

Opioid epidemic responses overlook gender

July 5, 2018
Yale health experts warn that current efforts to confront the growth of opioid addiction and overdose deaths must better incorporate an understanding of how women fit into this epidemic.

Increasing health insurance coverage for addiction treatment is key to fighting opioid deaths

June 28, 2018
People who suffer from an addiction to opioids and want to overcome their addiction should not be denied access to treatment by their insurance providers, according to new policy recommendations that were co-authored by Claudio ...

Expanding primary care buprenorphine treatment could curb opioid overdose crisis

July 4, 2018
Expanding the availability of medication treatment for opioid use disorder in primary care settings would be a major step toward reducing overdose deaths, write two physicians specializing in addiction medicine and health ...

Hospital staff experience 'sea change' in addressing substance use disorder

April 25, 2018
As the nation's opioid epidemic claims thousands of lives, more and more people are hospitalized with infections, overdoses, and other medical and surgical complications of substance use. This resonates across Oregon, with ...

Recommended for you

Novel botulinum toxin compound relieves chronic pain

July 18, 2018
A modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects and, in time, could replace opioid drugs as a safe and effective way of treating chronic pain, according to research by UCL, ...

FDA recalls heart medication valsartan, citing cancer concerns

July 17, 2018
The U.S. Food and Drug Administration issued a voluntary recall of several medications that contain the active ingredient valsartan, which is used to treat high blood pressure and heart failure.

Opioids given too easily to children: study

July 16, 2018
(HealthDay)—Many children are prescribed powerful opioid painkillers they don't really need, putting them and those around them at risk, a new study shows.

Study reveals opioid patients face multiple barriers to treatment

July 12, 2018
In areas of the country disproportionately affected by the opioid crisis, treatment programs are less likely to accept patients paying through insurance of any type or accept pregnant women, a new Vanderbilt study found.

Report details possible conflict of interest issues for FDA advisors

July 6, 2018
Charles Piller, a contributing correspondent for the journal Science, has published a Feature piece in the journal detailing what he describes as possible conflicts of interest issues by people who serve as advisors to the ...

Study finds no strong evidence that cannabis reduces chronic pain

July 4, 2018
A four-year study suggests medicinal cannabis is not as effective at relieving chronic non-cancer pain as commonly assumed.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.